Navigation Links
MedCath Names Parker to New Finance Post
Date:5/12/2008

care provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. Following completion of the divestiture of Dayton Heart Hospital, MedCath will own an interest in and operate nine hospitals with a total of 616 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota and Texas. In addition, MedCath and its subsidiary MedCath Partners manage the cardiovascular program at various hospitals and provide services in diagnostic and therapeutic facilities in various states.


'/>"/>
SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. MedCath Corporation to Present at the Banc of America Securities 2008 Health Care Conference
2. MedCath Corporation Reports Second Quarter Earnings
3. MedCath Corporation to Present at the Deutsche Bank Securities 33rd Annual Health Care Conference
4. MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook
5. Woodrin Woody Grossman Appointed to MedCaths Board of Directors
6. Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCaths Board of Directors
7. MedCath Announces Acquisition of Ownership in Arizona Cath Lab
8. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
9. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
10. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
11. MedCath Announces Venture With Two New Jersey Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...HINGTON, July 25 /PRNewswire/ -- Klafter & Olsen L...Care Corporation ("ArthroCare" or the,"Company") (... U.S. District,Court for the Western District of T...hased the common stock ArthroCare from January 24,...chaser Class Period") and all,persons or entities ...
(Date:7/25/2008)...ASANTON, Calif., July 25 /PRNewswire-FirstCall/ --...der in device-based mechanical,circulatory support...arts,today announced that it will report its oper... months of fiscal 2008 on Thursday, July 31., The...s financial,results and operating activities to al...
(Date:7/25/2008)...ROOK, Ill. July 25, 2008 The American Society f...idelines on the role of endoscopy in the bariatric... in the United States and the success in surgical ...er of weight-loss surgeries performed in the U.S.,...lines discuss endoscopy in the preoperative patien...
(Date:7/25/2008)...ivanCotter Releases Results of Fourth Annual Physi...urvey, DETROIT, July 25 /PRNewswire/ -- Sullivan,...rth annual survey of physician on-call pay rates a...y Report. The survey report,with data from 132 he...ian,on-call pay practices and rates paid for 33 ph...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3
...in turmeric and onions has been found to help prev... Hopkins investigators.// The research was led by ...versity School of Medicine and Dr. Marcia Cruz-Cor... University of Puerto Rico School of Medicine. G...
...r. Edward A. Hirschowitz and Dr. Li Zhong could he...o are at high risk for developing the disease. // ...in United States and around the world mainly becau...e. The incidence of lung cancer in Kentucky is 49...
...g in public to avoid embarrassment. Stains caused...ng these stains will soon become more affordable w...e with stains avoided treatment as the treatment o...ike veneering, crowns and bonding were too costly ...
... in Laos led to the mass culling of more than 200 ...ing village in northeastern Thailand.// Thai off...land through contaminated eggs trays. But they als...elp needed to fight the disease effectively. Lives...
Other Medicine News:Health News:New Blood Test For Early Detection Of Lung Cancer 2Health News:Treating Tetracycline Stains Made More Affordable With New Treatment 2Health News:Treating Tetracycline Stains Made More Affordable With New Treatment 3
(Date:7/22/2008)...firms Tyrima Exhibits Excellent Drug-Like ...Support Initiation of Phase II Clinical Trials -, .../ -- CeNeRx BioPharma,Inc., a clinical stage comp...tments for diseases of the central nervous system,...te Tyrima(TM) into Phase II trials for the,treatme...
(Date:7/22/2008)... the Importance to Patients of Passing a ...HMOND, Va., July 22 /- Insm... biologics and biopharmaceuticals, today,announced...resent at a,Congressional briefing on Friday, July...tablishing an approval pathway for follow-on,biolo...
(Date:7/22/2008)...motherapy and pegylated enzyme produces signifi...alone - - Pegylated enzyme well t...all/ -- Halozyme Therapeutics,Inc. (Nasdaq: HALO...mercializing products targeting the extracellular ...ve pre-clinical animal efficacy data,for its pegyl...
(Date:7/22/2008)...ser Lipolysis Technology in the European ...ly 22 /- Cynosure, Inc.,(Na...r of a broad array of,light-based aesthetic treatm... Smartlipo MPX(TM), the company,s high-powered, du... and tighten skin through collagen,remodeling. The...
Breaking Medicine Technology:CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3ExonHit and bioMerieux Amend Their Strategic Partnership 2522 1ExonHit and bioMerieux Amend Their Strategic Partnership 2522 2ExonHit and bioMerieux Amend Their Strategic Partnership 2522 3Looking Older 3F How Square is Your Jaw Line 3F 1177 1Looking Older 3F How Square is Your Jaw Line 3F 1177 2Uses of medications in psychoanalysis 9315 1Uses of medications in psychoanalysis 9315 25 Factors Help Predict Psychosis in Children 9314 15 Factors Help Predict Psychosis in Children 9314 25 Factors Help Predict Psychosis in Children 9314 3
...LONA, SPAIN and SEATTLE, WA -- (MARKET WIRE) -- Ju...AQ: TGEN) today is,reporting data from the dose es...udy of tgAAC94 in patients with inflammatory,arthr... the,University of Washington School of Medicine, ...dish Medical Center, practicing,physician with Sea...
...APOLIS, June 13, 2007 /PRNewswire/ -- Two studies ...affect body sway at peak,plasma levels, nor did it...emory performance in patients who suffer from chro...ented at the 21st,Annual Meeting of the Associated...a are important because they show that ROZEREM may...
Other Medicine Technology:Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 2Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 4Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 5
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...microscope technology that offers you much more th...s category. You will be impressed by the outstandi...n designed to make lab work as easy and safe as po...kflow. Your advantage: more time for the observati...
... advanced inverted microscope for automated live c...tion CFI60 optics, and extendible infinity design ...on, its super-nanoprecision z-axis motorized focus...for precise imaging in 3D. It's the first inverte...
... an innovative and efficient inverted routine micr...earch facility. , ,Outstanding Optical Performanc...ll magnifications. Objectives deliver superb optic...chromatic aberration free correction (CF), and top...
Medicine Products: